Dexa Group
From Molecule,
to Market
Five decades of end-to-end expertise in pharmaceutical discovery, formulation, manufacturing, and marketing — across Southeast Asia and the Asia Pacific.
Awards Earned
Primaniyarta
Award
Ministry
of Trade
of Trade
2005 • 2017-2019 • 2021
Indonesia's Most
Admired Companies
Warta
Ekonomi
Ekonomi
2017-2019
Top Brand
for Kids
Marketing
Magazine
Magazine
2009-2020 • 2022
Outstanding Corporate
Innovator
Product Development and
Management Association
Management Association
2018
IIRDI
Award
Ministry of Research
and Technology
and Technology
2018-2019
BPOM
Award
Food and Drug
Agency Indonesia
Agency Indonesia
2017
Dexa means Quality
Our name was inspired by the Greek δέκα, meaning 10 — a universal symbol of perfection. Even today, our work aspires to that same impossible standard. That’s why, for millions of people in 14 countries, Dexa means quality.
Our Companies
Indonesian Modern Herbal Medicines
We identify, extract, and test biomolecules embedded deep in nature. Then, we use these microscopic gems to produce herbal medicines that are extraordinarily safe and effective.
Dexa: A Snapshot
Employees
Patents
Trademarks
Pharmacies Covered Directly
International Alliances
Marketing Authorisations
Latest News
5 August 2022
Dexa Group's Commitment to Encourage the Production of Natural Medicine Raw Materials for National Independence
With more than 28000 plant species and 2,848 medicinal plants, Indonesia has the second-highest biodiversity in the world. Its natural resources hold tremendous promise for developing phytopharmaceuticals and herbal medicines, including Indonesia Indigenous Modern Medicine (IIMM). Penny K. Lukito, head of the Food and Drug Supervisory Agency (BPOM), stated that…
1 August 2022
Dexa Award Science Scholarship 2022 Stimulates Innovation to Build Health Independence
The Indonesian government continues to encourage the resilience and independence of the healthcare industry, as imports dominate 90% of its domestic pharmaceutical raw materials and health spending. In addition, 88% of medical device transactions through electronic catalogs (e-catalogs) are imported products. Meanwhile, research and development funds are only about 0.2%…
8 July 2022
Prevent Stunting, Dexa Group's Green Pharmacy Becomes The Partner of BKKBN
Indonesia's 29th National Family Day (Harganas) was celebrated with the theme "Let's Prevent Stunting for Stunting-Free Family". President Joko Widodo (Jokowi) said that the government had appointed the National Population and Family Planning Agency (BKKBN) to reduce the prevalence of stunting to 14% in 2024. Therefore, BKKBN collaborates with several…
6 July 2022
Mr. Ferry A. Soetikno as a Speaker at the Advisory Board Sharing Session #7: Drug Raw Material Independence as a Part of the Dynamics of the Indonesian Pharmaceutical Industry
The Covid-19 epidemic has given Indonesia's pharmaceutical sector a fresh start. In stark contrast to the average 5–10% growth rate, the pharmaceutical sector shrank by -1.6 percent. Meanwhile, a supply shock made it challenging for the nation to get medical raw materials (BBO) since imports met 90% of BBO requirements.…
1 July 2022
Actively Contributing to Overcoming Health Problems, Dexa Group Wins Indonesia Best CSR Award 2022
Dexa Group received the Outstanding Program in Prioritizing Public Health Needs award from Warta Ekonomi's Indonesia Best CSR Award 2022 for its contribution to the healthcare industry. This honor is granted in recognition of Dexa Group's significant work putting social responsibility and environmental responsibility initiatives into action. On Thursday, June…
25 June 2022
The 'Bangga Buatan Indonesia' Movement Promotes Pharmacy Product Independence
Dexa Group participated in the Proudly Made in Indonesia 2022 event once more to accelerate the independence of domestic local products. On Thursday, June 23, 2022, the Bangga Buatan Indonesia (BBI) event with the title Lagawi Fest (Lampung Bangga Wirausaha Industri Festival) Satu Bumi Juta Karya was held on Tegal…